These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group. ; Al Jasmi F; Al Jumah M; Alqarni F; Al-Sanna'a N; Al-Sharif F; Bohlega S; Cupler EJ; Fathalla W; Hamdan MA; Makhseed N; Nafissi S; Nilipour Y; Selim L; Shembesh N; Sunbul R; Tonekaboni SH BMC Neurol; 2015 Oct; 15():205. PubMed ID: 26471939 [TBL] [Abstract][Full Text] [Related]
9. Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel. Tarnopolsky M; Katzberg H; Petrof BJ; Sirrs S; Sarnat HB; Myers K; Dupré N; Dodig D; Genge A; Venance SL; Korngut L; Raiman J; Khan A Can J Neurol Sci; 2016 Jul; 43(4):472-85. PubMed ID: 27055517 [TBL] [Abstract][Full Text] [Related]
10. [Variability in the clinical presentation of Pompe disease in infancy: two case reports and response to treatment with human recombinant enzyme]. Moreno-Medinilla E; Berzosa-López R; Mora-Ramírez MD; Blasco-Alonso J; Martínez-Antón J Rev Neurol; 2014 Dec; 59(11):503-7. PubMed ID: 25418145 [TBL] [Abstract][Full Text] [Related]
11. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. Katzin LW; Amato AA J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of Pompe disease]. Bravo-Oro A; de la Fuente-Cortez B; Molina-García A; Romero-Díaz V; Rodríguez-Leyva I; Esmer-Sánchez Mdel C; Rev Med Inst Mex Seguro Soc; 2013; 51(5):536-51. PubMed ID: 24144148 [TBL] [Abstract][Full Text] [Related]
13. Newborn screening for Pompe disease: an update, 2011. Burton BK Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219 [TBL] [Abstract][Full Text] [Related]
14. Where do we stand in enzyme replacement therapy in Pompe's disease? van der Ploeg AT Neuromuscul Disord; 2010 Dec; 20(12):773-4. PubMed ID: 21094929 [No Abstract] [Full Text] [Related]
15. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease]. Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935 [TBL] [Abstract][Full Text] [Related]
16. [Should we consider newborn screening for Pompe disease?]. Lacombe D; Verloes A Arch Pediatr; 2014 Jun; 21(6):561-3. PubMed ID: 24768068 [No Abstract] [Full Text] [Related]
17. Effect of enzyme replacement therapy in late onset Pompe disease: open pilot study of 48 weeks follow-up. Park JS; Kim HG; Shin JH; Choi YC; Kim DS Neurol Sci; 2015 Apr; 36(4):599-605. PubMed ID: 25388776 [TBL] [Abstract][Full Text] [Related]
18. [Variability in the clinical presentation of Pompe disease: development following enzyme replacement therapy]. Ley-Martos M; Salado-Reyes MJ; Espinosa-Rosso R; Solera-García J; Jiménez-Jiménez L Rev Neurol; 2015 Nov; 61(9):416-20. PubMed ID: 26503317 [TBL] [Abstract][Full Text] [Related]